Thyroid hormone receptors and resistance to thyroid hormone disorders

Nature Reviews Endocrinology

Volumn 10, Issue 10, 2014, Pages 582-591

  Ortiga Carvalho, Tânia M ^a   Sidhaye, Aniket R ^b   Wondisford, Fredric E ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROID HORMONE; THYROID HORMONE RECEPTOR; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR BETA;

CLINICAL FEATURE; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE MODEL; FEEDBACK SYSTEM; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENOMICS; GROWTH DISORDER; HEART FUNCTION; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HYPOPHYSIS THYROID SYSTEM; MOLECULAR PATHOLOGY; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; THYROID HORMONE RESISTANCE; ANIMAL; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY; THYROID DISEASES;

ANIMALS; HUMANS; MUTATION; RECEPTORS, THYROID HORMONE; THYROID DISEASES; THYROID HORMONES;

EID: 84926213035     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2014.143     Document Type: Review

References (106)

1. Cheng, S. Y., Leonard, J. L. & Davis, P. J. Molecular aspects of thyroid hormone actions. Endocr. Rev. 31, 139-170 (2010).
2. Brent, G. A. Mechanisms of thyroid hormone action. J. Clin. Invest. 122, 3035-3043 (2012).
3. Chiamolera, M. I. & Wondisford, F. E. Minireview: Thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. Endocrinology 150, 1091-1096 (2009).
4. Nikrodhanond, A. A. et al. Dominant role of thyrotropin-releasing hormone in the hypothalamic-pituitary-thyroid axis. J. Biol. Chem. 281, 5000-5007 (2006).
5. Gereben, B. et al. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr. Rev. 29, 898-938 (2008).
6. Bianco, A. C. Minireview: cracking the metabolic code for thyroid hormone signaling. Endocrinology 152, 3306-3311 (2011).
7. Chiamolera, M. I. et al. Fundamentally distinct roles of thyroid hormone receptor isoforms in a thyrotroph cell line are due to differential DNA binding. Mol. Endocrinol. 26, 926-939 (2012).
8. Sap, J. et al. The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 324, 635-640 (1986).
9. Oetting, A. & Yen, P. M. New insights into thyroid hormone action. Best Pract. Res. Clin. Endocrinol. Metab. 21, 193-208 (2007).
10. Refetoff, S. et al. Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. Thyroid 24, 407-409 (2014).
11. Shibusawa, N. et al. Thyroid hormone action in the absence of thyroid hormone receptor DNA-binding in vivo. J. Clin. Invest. 112, 588-597 (2003).
12. Ortiga-Carvalho, T. M. et al. Negative regulation by thyroid hormone receptor requires an intact coactivator-binding surface. J. Clin. Invest. 115, 2517-2523 (2005).
13. Kaneshige, M. et al. Mice with a targeted mutation in the thyroid hormone' receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc. Natl Acad. Sci. USA 97, 13209-13214 (2000).
14. Ferrara, A. M. et al. Homozygous thyroid hormone receptor'-gene mutations in resistance to thyroid hormone: three new cases and review of the literature. J. Clin. Endocrinol. Metab. 97, 1328-1336 (2012).
15. Kaneshige, M. et al. A targeted dominant negative mutation of the thyroid hormone'1 receptor causes increased mortality, infertility, and dwarfism in mice. Proc. Natl Acad. Sci. USA 98, 15095-15100 (2001).
16. Bochukova, E. et al. A mutation in the thyroid hormone receptor' gene. N. Engl. J. Med. 366, 243-249 (2012).
17. Moran, C. et al. Resistance to thyroid hormone caused by a mutation in thyroid hormone receptor (TR)'1 and TR'2: clinical, biochemical, and genetic analyses of three related patients. Lancet Diabetes Endocrinol. http://dx.doi.org/10.1016/S2213-8587(14)70111-1.
18. Moran, C. et al. An adult female with resistance to thyroid hormone mediated by defective thyroid hormone receptor'. J. Clin. Endocrinol. Metab. 98, 4254-4261 (2013).
19. van Mullem, A. et al. Clinical phenotype and mutant TR'1. N. Engl. J. Med. 366, 1451-1453 (2012).
20. Refetoff, S. & Dumitrescu, A. M. Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract. Res. Clin. Endocrinol. Metab. 21, 277-305 (2007).
21. Phan, T. Q., Jow, M. M. & Privalsky, M. L. DNA recognition by thyroid hormone and retinoic acid receptors: 3, 4, 5 rule modified. Mol. Cell Endocrinol. 319, 88-98 (2010).
22. Warnmark, A., Treuter, E., Wright, A. P. & Gustafsson, J. A. Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. Mol. Endocrinol. 17, 1901-1909 (2003).
23. Figueira, A. C. et al. Analysis of agonist and antagonist effects on thyroid hormone receptor conformation by hydrogen/deuterium exchange. Mol. Endocrinol. 25, 15-31 (2011).
24. Chassande, O. et al. Identification of transcripts initiated from an internal promoter in the c-erbA' locus that encode inhibitors of retinoic acid receptor-' and triiodothyronine receptor activities. Mol. Endocrinol. 11, 1278-1290 (1997).
25. Gauthier, K. et al. Different functions for the thyroid hormone receptors TR' and TR' in the control of thyroid hormone production and post-natal development. EMBO J. 18, 623-631 (1999).
26. Williams, G. R. Cloning and characterization of two novel thyroid hormone receptor' isoforms. Mol. Cell Biol. 20, 8329-8342 (2000).
27. Wallis, K. et al. The thyroid hormone receptor'1 protein is expressed in embryonic postmitotic neurons and persists in most adult neurons. Mol. Endocrinol. 24, 1904-1916 (2010).
28. Bradley, D. J., Towle, H. C. & Young, W. S. 3rd. Spatial and temporal expression of'-and'-thyroid hormone receptor mRNAs, including the'2-subtype, in the developing mammalian nervous system. J. Neurosci. 12, 2288-2302 (1992).
29. Bradley, D. J., Towle, H. C. & Young, W. S. 3rd.' and' thyroid hormone receptor (TR) gene expression during auditory neurogenesis: evidence for TR isoform-specific transcriptional regulation in vivo. Proc. Natl Acad. Sci. USA 91, 439-443 (1994).
30. Kilby, M. D. et al. Circulating thyroid hormone concentrations and placental thyroid hormone receptor expression in normal human pregnancy and pregnancy complicated by intrauterine growth restriction (IUGR). J. Clin. Endocrinol. Metab. 83, 2964-2971 (1998).
31. Feng, X., Jiang, Y., Meltzer, P. & Yen, P. M. Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol. Endocrinol. 14, 947-955 (2000).
32. Flores-Morales, A. et al. Patterns of liver gene expression governed by TR'. Mol. Endocrinol. 16, 1257-1268 (2002).
33. de Araujo, A. S., Martinez, L., de Paula Nicoluci, R., Skaf, M. S. & Polikarpov, I. Structural modeling of high-affinity thyroid receptor-ligand complexes. Eur. Biophys. J. 39, 1523-1536 (2010).
34. Valadares, N. F., Polikarpov, I. & Garratt, R. C. Ligand induced interaction of thyroid hormone receptor' with its coregulators. J. Steroid Biochem. Mol. Biol. 112, 205-212 (2008).
35. Weiss, R. E. et al. Dominant inheritance of resistance to thyroid hormone not linked to defects in the thyroid hormone receptor' or' genes may be due to a defective cofactor. J. Clin. Endocrinol. Metab. 81, 4196-4203 (1996).
36. Souza, P. C. et al. Helix 12 dynamics and thyroid hormone receptor activity: experimental and molecular dynamics studies of Ile280 mutants. J. Mol. Biol. 412, 882-893 (2011).
37. Alonso, M. et al. In vivo interaction of steroid receptor coactivator (SRC)-1 and the activation function-2 domain of the thyroid hormone receptor (TR)' in TR' E457A knock-in and SRC-1 knockout mice. Endocrinology 150, 3927-3934 (2009).
38. Lavery, D. N. & McEwan, I. J. Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations. Biochem. J. 391, 449-464 (2005).
39. Cohen, R. N. et al. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains. Mol. Endocrinol. 15, 1049-1061 (2001).
40. Hollenberg, A. N., Monden, T. & Wondisford, F. E. Ligand-independent and-dependent functions of thyroid hormone receptor isoforms depend upon their distinct amino termini. J. Biol. Chem. 270, 14274-14280 (1995).
41. Hashimoto, K. et al. Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model. J. Biol. Chem. 281, 295-302 (2006).
42. Liu, Y. Y. et al. A mutant thyroid hormone receptor' antagonizes peroxisome proliferator-activated receptor' signaling in vivo and impairs fatty acid oxidation. Endocrinology 148, 1206-1217 (2007).
43. Brent, G. A. et al. Capacity for cooperative binding of thyroid hormone (T3) receptor dimers defines wild type T3 response elements. Mol. Endocrinol. 6, 502-514 (1992).
44. Ayers, S. et al. Genome-wide binding patterns of thyroid hormone receptor'. PLoS One 9, e81186 (2014).
45. Chatonnet, F., Guyot, R., Benoit, G. & Flamant, F. Genome-wide analysis of thyroid hormone receptors shared and specific functions in neural cells. Proc. Natl Acad. Sci. USA 110, E766-E775 (2013).
46. Astapova, I. et al. The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo. Proc. Natl Acad. Sci. USA 105, 19544-19549 (2008).
47. Feng, W. et al. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 280, 1747-1749 (1998).
48. Darimont, B. D. et al. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12, 3343-3356 (1998).
49. McKenna, N. J. et al. Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J. Steroid Biochem. Mol. Biol. 69, 3-12 (1999).
50. Shibusawa, N., Hollenberg, A. N. & Wondisford, F. E. Thyroid hormone receptor DNA binding is required for both positive and negative gene regulation. J. Biol. Chem. 278, 732-738 (2003).
51. Sasaki, S. et al. Ligand-induced recruitment of a histone deacetylase in the negative-feedback regulation of the thyrotropin' gene. EMBO J. 18, 5389-5398 (1999).
52. Santos, G. M. et al. Negative regulation of superoxide dismutase-1 promoter by thyroid hormone. Mol. Pharmacol. 70, 793-800 (2006).
53. Weiss, R. E. et al. Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone. EMBO J. 18, 1900-1904 (1999).
54. Kamiya, Y. et al. Modulation by steroid receptor coactivator-1 of target-tissue responsiveness in resistance to thyroid hormone. Endocrinology 144, 4144-4153 (2003).
55. Costa-e-Sousa, R. H., Astapova, I., Ye, F., Wondisford, F. E. & Hollenberg, A. N. The thyroid axis is regulated by NCoR1 via its actions in the pituitary. Endocrinology 153, 5049-5057 (2012).
56. Aninye, I. O., Matsumoto, S., Sidhaye, A. R. & Wondisford, F. E. Circadian regulation of Tshb gene expression by Rev-Erb' (NR1D1) and nuclear corepressor 1 (NCOR1). J. Biol. Chem. 289, 17070-17077 (2014).
57. Treuter, E., Albrektsen, T., Johansson, L., Leers, J. & Gustafsson, J. A. A regulatory role for RIP140 in nuclear receptor activation. Mol. Endocrinol. 12, 864-881 (1998).
58. Ramadoss, P. et al. Novel mechanism of positive versus negative regulation by thyroid hormone receptor'1 (TR'1) identified by genome-wide profiling of binding sites in mouse liver. J. Biol. Chem. 289, 1313-1328 (2014).
59. Abel, E. D., Ahima, R. S., Boers, M. E., Elmquist, J. K. & Wondisford, F. E. Critical role for thyroid hormone receptor'2 in the regulation of paraventricular thyrotropin-releasing hormone neurons. J. Clin. Invest. 107, 1017-1023 (2001).
60. Gauthier, K. et al. Genetic analysis reveals different functions for the products of the thyroid hormone receptor' locus. Mol. Cell Biol. 21, 4748-4760 (2001).
61. Macchia, P. E. et al. Increased sensitivity to thyroid hormone in mice with complete deficiency of thyroid hormone receptor'. Proc. Natl Acad. Sci. USA 98, 349-354 (2001).
62. Gothe, S. et al. Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev. 13, 1329-1341 (1999).
63. Pazos-Moura, C. et al. Cardiac dysfunction caused by myocardium-specific expression of a mutant thyroid hormone receptor. Circ. Res. 86, 700-706 (2000).
64. Ono, S. et al. Homozygosity for a dominant negative thyroid hormone receptor gene responsible for generalized resistance to thyroid hormone. J. Clin. Endocrinol. Metab. 73, 990-994 (1991).
65. Usala, S. J. et al. A homozygous deletion in the c-erbA' thyroid hormone receptor gene in a patient with generalized thyroid hormone resistance: isolation and characterization of the mutant receptor. Mol. Endocrinol. 5, 327-335 (1991).
66. Takeda, K., Sakurai, A., DeGroot, L. J. & Refetoff, S. Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor-' gene. J. Clin. Endocrinol. Metab. 74, 49-55 (1992).
67. van Mullem, A. A. et al. Clinical phenotype of a new type of thyroid hormone resistance caused by a mutation of the TR'1 receptor: consequences of LT4 treatment. J. Clin. Endocrinol. Metab. 98, 3029-3038 (2013).
68. Forrest, D., Erway, L. C., Ng, L., Altschuler, R. & Curran, T. Thyroid hormone receptor' is essential for development of auditory function. Nat. Genet. 13, 354-357 (1996).
69. Forrest, D. & Vennstrom, B. Functions of thyroid hormone receptors in mice. Thyroid 10, 41-52 (2000).
70. Abel, E. D. et al. Divergent roles for thyroid hormone receptor' isoforms in the endocrine axis and auditory system. J. Clin. Invest. 104, 291-300 (1999).
71. Dettling, J. et al. Autonomous functions of murine thyroid hormone receptor TR' and TR' in cochlear hair cells. Mol. Cell Endocrinol. 382, 26-37 (2013).
72. Portella, A. C. et al. Thyroid hormone receptor' mutation causes severe impairment of cerebellar development. Mol. Cell Neurosci. 44, 68-77 (2010).
73. Hashimoto, K. et al. An unliganded thyroid hormone receptor causes severe neurological dysfunction. Proc. Natl Acad. Sci. USA 98, 3998-4003 (2001).
74. Machado, D. S. et al. A thyroid hormone receptor mutation that dissociates thyroid hormone regulation of gene expression in vivo. Proc. Natl Acad. Sci. USA 106, 9441-9446 (2009).
75. Parrilla, R., Mixson, A. J., McPherson, J. A., McClaskey, J. H. & Weintraub, B. D. Characterization of seven novel mutations of the c-erbA' gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain. J. Clin. Invest. 88, 2123-2130 (1991).
76. Flynn, T. R. et al. A novel C-terminal domain in the thyroid hormone receptor selectively mediates thyroid hormone inhibition. J. Biol. Chem. 269, 32713-32716 (1994).
77. Faustino, L. C. et al. Liver glutathione S-transferase' expression is decreased by T3 in hypothyroidism but not in euthyroidism in mice. Exp. Physiol. 96, 790-800 (2011).
78. Cordas, E. A. et al. Thyroid hormone receptors control developmental maturation of the middle ear and the size of the ossicular bones. Endocrinology 153, 1548-1560 (2012).
79. Richter, C. P., Munscher, A., Machado, D. S., Wondisford, F. E. & Ortiga-Carvalho, T. M. Complete activation of thyroid hormone receptor' by T3 is essential for normal cochlear function and morphology in mice. Cell Physiol. Biochem. 28, 997-1008 (2011).
80. Pessoa, C. N. et al. Thyroid hormone action is required for normal cone opsin expression during mouse retinal development. Invest. Ophthalmol. Vis. Sci. 49, 2039-2045 (2008).
81. Ng, L. et al. A thyroid hormone receptor that is required for the development of green cone photoreceptors. Nat. Genet. 27, 94-98 (2001).
82. Roberts, M. R., Srinivas, M., Forrest, D., Morreale de Escobar, G. & Reh, T. A. Making the gradient: thyroid hormone regulates cone opsin expression in the developing mouse retina. Proc. Natl Acad. Sci. USA 103, 6218-6223 (2006).
83. Weiss, A. H., Kelly, J. P., Bisset, D. & Deeb, S. S. Reduced L-and M-and increased S-cone functions in an infant with thyroid hormone resistance due to mutations in the THR'2 gene. Ophthalmic Genet. 33, 187-195 (2012).
84. Mangelsdorf, D. J. & Evans, R. M. The RXR heterodimers and orphan receptors. Cell 83, 841-850 (1995).
85. Hollenberg, A. N., Monden, T., Madura, J. P., Lee, K. & Wondisford, F. E. Function of nuclear co-repressor protein on thyroid hormone response elements is regulated by the receptor A/B domain. J. Biol. Chem. 271, 28516-28520 (1996).
86. Liu, Y., Xia, X., Fondell, J. D. & Yen, P. M. Thyroid hormone-regulated target genes have distinct patterns of coactivator recruitment and histone acetylation. Mol. Endocrinol. 20, 483-490 (2006).
87. Fozzatti, L. et al. Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1). Proc. Natl Acad. Sci. USA 108, 17462-17467 (2011).
88. Swanson, E. A. et al. Cardiac expression and function of thyroid hormone receptor' and its PV mutant. Endocrinology 144, 4820-4825 (2003).
89. Suarez, J., Scott, B. T., Suarez-Ramirez, J. A., Chavira, C. V. & Dillmann, W. H. Thyroid hormone inhibits ERK phosphorylation in pressure overload-induced hypertrophied mouse hearts through a receptor-mediated mechanism. Am. J. Physiol. Cell Physiol. 299, C1524-C1529 (2010).
90. Gloss, B. et al. Cardiac ion channel expression and contractile function in mice with deletion of thyroid hormone receptor' or'. Endocrinology 142, 544-550 (2001).
91. Gloss, B. et al. Altered cardiac phenotype in transgenic mice carrying the'337 threonine thyroid hormone receptor' mutant derived from the S family. Endocrinology 140, 897-902 (1999).
92. Ortiga-Carvalho, T. M. et al. Thyroid hormone resistance in the heart: role of the thyroid hormone receptor' isoform. Endocrinology 145, 1625-1633 (2004).
93. Safer, J. D. et al. Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone. Mol. Endocrinol. 11, 16-26 (1997).
94. Wagner, R. L. et al. A structural role for hormone in the thyroid hormone receptor. Nature 378, 690-697 (1995).
95. Nagaya, T. & Jameson, J. L. Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistance. J. Biol. Chem. 268, 15766-15771 (1993).
96. Yen, P. M., Wilcox, E. C., Hayashi, Y., Refetoff, S. & Chin, W. W. Studies on the repression of basal transcription (silencing) by artificial and natural human thyroid hormone receptor-' mutants. Endocrinology 136, 2845-2851 (1995).
97. Monden, T. et al. Leucine at codon 428 in the ninth heptad of thyroid hormone receptor'1 is necessary for interactions with the transcriptional cofactors and functions regardless of dimer formations. Thyroid 13, 427-435 (2003).
98. Fraichard, A. et al. The T3R' gene encoding a thyroid hormone receptor is essential for post-natal development and thyroid hormone production. EMBO J. 16, 4412-4420 (1997).
99. O'Shea, P. J. et al. A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormone. Mol. Endocrinol. 17, 1410-1424 (2003).
100. O'Shea, P. J. et al. Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor'1 or'. Mol. Endocrinol. 19, 3045-3059 (2005).
101. Quignodon, L., Vincent, S., Winter, H., Samarut, J. & Flamant, F. A point mutation in the activation function 2 domain of thyroid hormone receptor'1 expressed after CRE-mediated recombination partially recapitulates hypothyroidism. Mol. Endocrinol. 21, 2350-2360 (2007).
102. Fauquier, T. et al. Purkinje cells and Bergmann glia are primary targets of the TR'1 thyroid hormone receptor during mouse cerebellum postnatal development. Development 141, 166-175 (2014).
103. Adams, M. et al. Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor' gene. J. Clin. Invest. 94, 506-515 (1994).
104. Tinnikov, A. et al. Retardation of post-natal development caused by a negatively acting thyroid hormone receptor'1. EMBO J. 21, 5079-5087 (2002).
105. Refetoff, S., DeWind, L. T. & DeGroot L. J. Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J. Clin. Endocrinol. Metab. 27, 279-294 (1967).
106. Liu, Y. Y., Schultz, J. J. & Brent, G. A. A thyroid hormone receptor' gene mutation (P398H) is associated with visceral adiposity and impaired catecholamine-stimulated lipolysis in mice. J. Biol. Chem. 278, 38913-38920 (2003).